Erowid References Database
|
Hanes KR.
“Serotonin, psilocybin, and body dysmorphic disorder: a case report.
”.
J Clin Psychopharmacology. 1996 Apr;16(2):188-9.
|
|
Abstract
Body dysmorphic disorder, preoccupation with an imagined defect in appearance, or excessive concern with a slight physical anomaly, has been successfully treated recently with serotonin reuptake inhibitor (SSRI) medication [1,2], which has led to the proposition of a possible serotonergic basis for this disorder [1,2]. Further evidence of this theory comes from reports of exacerbation of body dysmorphic disorder during tryptophan depletion [3] and use of the 5-HT antagonist cyproheptadine [4]. In support of this theory we present a case in which body dysmorphic symptoms were qualitatively altered with the ingestion of psilocybin, a potent serotonergic agent [5] in a patient who later responded to the SSRI fluoxetine.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
